NO20002590L - Formuleringer omfattende oppløst paroxetin - Google Patents

Formuleringer omfattende oppløst paroxetin

Info

Publication number
NO20002590L
NO20002590L NO20002590A NO20002590A NO20002590L NO 20002590 L NO20002590 L NO 20002590L NO 20002590 A NO20002590 A NO 20002590A NO 20002590 A NO20002590 A NO 20002590A NO 20002590 L NO20002590 L NO 20002590L
Authority
NO
Norway
Prior art keywords
paroxetine
solid
formulations
solutions
dissolved
Prior art date
Application number
NO20002590A
Other languages
English (en)
Other versions
NO20002590D0 (no
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20002590D0 publication Critical patent/NO20002590D0/no
Publication of NO20002590L publication Critical patent/NO20002590L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives farmasøytiske formuleringer av paroxetin, hvor paroxetinet er i løsning i en fast, halvfast eller flytende bærer. Løsningene benyttes til fylling av kapsler, eller selvbærende faste løsninger formes til faste doseringsformer som tabletter eller pellets. Det beskrives også nye flytende formuleringer, hvor et solubiliseringsmiddel benyttes til å solubilisere paroxetin i oljer og/eller lipider, samt fremgangsmåter for å unngå at andre paroxetinformer omdannes til hemihydratet, ved bruk av vannfrie eller hydrofobe bærere eller hjelpestoffer.
NO20002590A 1997-11-21 2000-05-19 Formuleringer omfattende oppløst paroxetin NO20002590L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Publications (2)

Publication Number Publication Date
NO20002590D0 NO20002590D0 (no) 2000-05-19
NO20002590L true NO20002590L (no) 2000-07-19

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002590A NO20002590L (no) 1997-11-21 2000-05-19 Formuleringer omfattende oppløst paroxetin

Country Status (24)

Country Link
EP (1) EP1033986A1 (no)
JP (1) JP2001523718A (no)
KR (1) KR20010032320A (no)
CN (1) CN1279608A (no)
AP (1) AP2000001821A0 (no)
AR (1) AR015485A1 (no)
AU (1) AU1168099A (no)
BG (1) BG104527A (no)
BR (1) BR9814220A (no)
CO (1) CO4970832A1 (no)
DZ (1) DZ2658A1 (no)
EA (1) EA200000552A1 (no)
GB (1) GB9724544D0 (no)
HU (1) HUP0100580A3 (no)
IL (1) IL136106A0 (no)
MA (1) MA24704A1 (no)
NO (1) NO20002590L (no)
OA (1) OA11385A (no)
PE (1) PE20000381A1 (no)
PL (1) PL340555A1 (no)
SK (1) SK7342000A3 (no)
TR (1) TR200001423T2 (no)
WO (1) WO1999026625A1 (no)
ZA (1) ZA9810637B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
JP4854115B2 (ja) * 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
ES2206254T3 (es) 1999-07-01 2004-05-16 Italfarmaco S.P.A. Complejos de paroxetina con ciclodextrinas o derivados de ciclodextrinas.
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
US20120322752A1 (en) * 2009-12-08 2012-12-20 Sung Kyun Lee SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3768536B2 (ja) * 1995-04-03 2006-04-19 アボツト・ラボラトリーズ 低温溶融性薬物と制御放出のための添加物との均質混合物
EA002034B1 (ru) * 1997-01-15 2001-12-24 Смитклайн Бичам Плс Композиция на основе пароксетина

Also Published As

Publication number Publication date
WO1999026625A1 (en) 1999-06-03
DZ2658A1 (fr) 2003-03-22
AU1168099A (en) 1999-06-15
OA11385A (en) 2004-01-27
EA200000552A1 (ru) 2000-10-30
CN1279608A (zh) 2001-01-10
PE20000381A1 (es) 2000-05-07
GB9724544D0 (en) 1998-01-21
AR015485A1 (es) 2001-05-02
CO4970832A1 (es) 2000-11-07
NO20002590D0 (no) 2000-05-19
KR20010032320A (ko) 2001-04-16
HUP0100580A3 (en) 2002-05-28
SK7342000A3 (en) 2000-12-11
HUP0100580A2 (hu) 2002-04-29
TR200001423T2 (tr) 2000-10-23
BG104527A (en) 2001-04-30
AP2000001821A0 (en) 2000-06-30
EP1033986A1 (en) 2000-09-13
JP2001523718A (ja) 2001-11-27
ZA9810637B (en) 2000-05-22
MA24704A1 (fr) 1999-07-01
BR9814220A (pt) 2001-12-26
IL136106A0 (en) 2001-05-20
PL340555A1 (en) 2001-02-12

Similar Documents

Publication Publication Date Title
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
NO20002590L (no) Formuleringer omfattende oppløst paroxetin
GB2314508A (en) Diamide-dicarboxylic acid microspheres
ATE307569T1 (de) Gelierbare pharmazeutische zusammensetzungen
NO20002133D0 (no) Oppløsninger og dispersjoner i fast tilstand av svakt vannoppløselige legemidler
ES2196621T3 (es) Sistemas de administracion de farmacos que utilizan estructuras de cristal liquido.
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
DK0501985T3 (da) Uovertrukket farmaceutisk reaktionstablet
UA74339C2 (uk) Форма для введення, що включає інгібітор протонної помпи у вигляді окремих одиниць, та спосіб їх одержання
ATE215370T1 (de) Selbstemulgierende formulierung enthaltend lipophile verbindungen
DE69940674D1 (de) Orale verabreichung von adenosin analogen
ES2035821T3 (es) Sistema de administracion enterica dirigida.
DE58902457D1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
ES2029776T1 (es) Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con una alta estabilidad.
SV2002000301A (es) Composicion farmaceutica ref. z-1032
KR860002270A (ko) 니트렌디핀을 함유하는 고상 약제 및 그의 제조방법
RU2000131588A (ru) Фармацевтическая композиция
DE69427981D1 (de) Verkapselter arzneistoff
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
FR2799660B1 (fr) Procede d'extraction par fluide supercritique
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
Wiseman et al. The distribution, excretion and metabolism of benzquinamide
DK0624365T3 (da) Farmaceutisk form til rectal administrering af farmakologisk aktive forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application